Vena Caval Filters in Pulmonary Embolism

ABSTRACT

Since the early 1900s, surgical interruption of the inferior vena cava (IVC) has been utilized in the management of venous thromboembolism (VTE). With the advent of newer-generation percutaneous devices in the late 1970s, their use and indications have expanded. The literature to support their efficacy, however, is limited to several case series and a single randomized controlled trial. Despite this, some have advocated the use of IVC filters as primary treatment of VTE in certain patient populations. In addition, there has been a large amount of interest in their use as prophylaxis against pulmonary embolism (PE) in high-risk patients. In the past 10 years, we have also seen the development and initial use of temporary devices, although their role in the management of this disease is even less certain. This article will review the recent literature on efficacy, complications, and indications for the use of IVC filters in the prevention and treatment of PE.

KEYWORD

Pulmonary embolism - deep venous thrombosis - inferior vena caval filters

REFERENCES

• 1 Shilz R J, Wirth J. Use of vena cava filters in the management of venous thromboembolic disease. PCCU (On line) 1999; 14(3)
• 2 Albert J, Smith R, Carlson J. Mortality in patients treated for pulmonary embolism.  JAMA . 1976;  236 1477-1480
• 3 Whitehill T A. Current vena cava filter devices and results.  Semin Vasc Surg . 2000;  13(3) 204-212
• 4 Ferris E J, McCowan T C, Carver D K, McFarland D R. Percutaneous inferior vena caval filters: follow-up of seven designs in 320 patients [see comments].  Radiology . 1993;  188(3) 851-856
• 5 Greenfield L J, Michan B A. Twelve-year clinical experience with the Greenfield vena caval filter.  Surgery . 1988;  104 706-712
• 6 Athanasoulis C A, Kaufman J A, Halpern E F, Waltman A C, Geller S C, Fan C. Inferior vena caval filters: review of a 26-year single-center clinical experience.  Radiology . 2000;  216(1) 54-66
• 7 Ballew K A, Philbrick J T, Becker D M. Vena cava filter devices.  Clin Chest Med . 1995;  16(2) 295-305
• 8 Nicholson A A, Ettles D F, Paddon A J, Dyet J F. Long-term follow-up of the Bird's Nest IVC filter.  Clin Radiol . 1999;  54 759-764
• 9 Streiff M B. Vena caval filters: a comprehensive review.  Blood . 2000;  95(12) 3669-3677
• 10 White R H, Zhou H, Kim J, Romano P S. A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism.  Arch Intern Med . 2000;  160 2033-2041
• 11 Crochet D P, Stora O, Ferry D. Vena Tech-LGM filter: long-term results of a prospective study.  Radiology . 1993;  188(3) 857-860
• 12 Decousus H, Leizorovicz A, Parent F. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis.  N Engl J Med . 1998;  338(7) 409-415
• 13 Haire W D. Vena caval filters for the prevention of pulmonary embolism.  N Engl J Med . 1998;  338(7) 463-464
• 14 Greenfield L J, Proctor M C. Filter complications and their management.  Semin Vasc Surg . 2000;  13(3) 213-216
• 15 Blebea J, Wilson R, Waybill P. Deep venous thrombosis after percutaneous insertion of vena caval filters.  J Vasc Surg . 1999;  30(5) 821-829
• 16 Jones B T, Fink J A. A prospective comparison of the status of the deep venous system after treatment with intracaval interruption versus anticoagulation.  J Am Coll Surg . 1994;  178 220-222
• 17 Rogers F B, Strindberg G, Shackford S R. Five-year follow-up of prophylactic vena cava filters in high-risk trauma patients.  Arch Surg . 1998;  133 406-411
• 18 Girard P, Tardy B, Decousus H. Inferior vena cava interruption: how and when?.  Annu Rev Med . 2000;  51 1-15
• 19 Rodriguez J L, Lopez J M, Proctor M C. Early placement of prophylactic vena cava filters in injured patients at high risk for pulmonary embolism.  J Trauma . 1996;  40(5) 797-804
• 20 Proctor M C. Indications for filter placement.  Semin Vasc Surg . 2000;  13(3) 194-198
• 21 Hyers T M, Agnelli G, Hurd R D. Antithrombotic therapy for venous thromboembolic disease.  Chest . 2001 (suppl 1);  119 (176S-193S)
• 22 Schilz R, Wirth J. Vena cava filters: expanding indications and practices.  Clin Pulm Med . 2000;  7(1) 41-47
• 23 Barritt D W, Jordan S C. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial.  Lancet . 1960;  1 1309-1312
• 24 Monreal M, Ruiz J, Salvador R. Recurrent pulmonary embolism: a prospective study.  Chest . 1989;  95 976-979
• 25 Norris C S, Greenfield L J, Herrmann J B. Free-floating ileofemoral thrombus: a risk of pulmonary embolism.  Arch Surg . 1985;  120 806-808
• 26 Pacouret G, Alison D, Pottier J, Bertrand P, Charbonnier B. Free-floating thrombus and embolic risk in patients with angiographically confirmed deep venous thrombosis. A prospective study.  Arch Int Med . 1997;  157 305-308
• 27 Cohen J R, Tenenbaum N, Citron M. Greenfield filter as primary therapy for deep venous thrombosis and/or pulmonary embolism in patients with cancer.  Surgery . 1991;  109(1) 12-15
• 28 Cohen J R, Grella L, Citron M. Greenfield filter instead of heparin as primary treatment for deep venous thrombosis or pulmonary embolism in patients with cancer.  Cancer . 1992;  70(7) 1993-1996
• 29 Fink J A, Jones B T. The Greenfield filter as the primary means of therapy in venous thromboembolic disease.  Surg Gynecol Obstet . 1991;  172(4) 253-256
• 30 Ihnat D M, Mills J L, Hughes J D, Gentile A T, Berman S S, Westerband A. Treatment of patients with venous thromboembolism and malignant disease: should vena cava filter placement be routine?.  J Vasc Surg . 1998;  28(5) 800-807
• 31 Levin J M, Schiff D, Loeffler J S, Fine H A, Black P M, Wen P Y. Complications of therapy for venous thromboembolic disease in patients with brain tumors.  Neurology . 1993;  43 1111-1114
• 32 Sarasin F P, Eckman M H. Management of prevention of thromboembolic events in patients with cancer-related hypercoaguable states: a risky business.  J Gen Intern Med . 1993;  8 476-486
• 33 Schiff D, DeAngelis L M. Therapy of venous thromboembolism in patients with brain metastases.  Cancer . 1994;  73(2) 493-498
• 34 Greenfield L J, Proctor M C, Michaels A J, Taheri P A. Prophylactic vena cava filters in trauma: the rest of the story.  J Vasc Surg . 2000;  32(3) 490-497
• 35 Hughes G C, Smith T P, Eachempati S R, Vaslef S N, Reed R L. The use of a temporary vena caval interruption device in high risk trauma patients unable to receive standard thromboembolism prophylaxis.  J Trauma . 1999;  46(2) 246-249
• 36 Khansarinia S, Dennis J W, Veldenz H C, Butcher J L, Hartland L. Prophylactic Greenfield filter placement in selected high-risk trauma patients.  J Vasc Surg . 1995;  22 231-236
• 37 Langan E M, Miller R S, Casey W J, Carsten C G, Graham R M, Taylor S M. Prophylactic inferior vena cava filters in trauma patients at high risk: follow-up examination and risk/benefit assessment.  J Vasc Surg . 1999;  30(3) 484-490
• 38 McMurtry A L, Owings J T, Anderson J T, Battistella F D, Gosselin R. Increased use of prophylactic vena cava filters in trauma patients failed to decrease overall incidence of pulmonary embolism.  J Am Coll Surg . 1999;  189(3) 314-320
• 39 Velmahos G C, Oh Y, McCombs J, Oder D. An evidence-based cost effectiveness model on methods of prevention of posttraumatic venous thromboembolism.  J Trauma . 2000;  49(6) 1059-1064
• 40 Velmahos G C, Kern J, Chan L S, Oder D, Murray J A, Shekelle P. Prevention of venous thromboembolism after injury: an evidence-based report-Part II: analysis of risk factors and evaluation of the role of vena caval filters.  J Trauma . 2000;  49 140-144
• 41 Agnelli G. Venous thromboembolism and cancer: a two-way clinical association.  Thromb Haemost . 1997;  78 117-120
• 42 Krauth D, Holden A, Knapic N, Liepman M, Ansell J. Safety and efficacy of long-term oral anticoagulation in cancer patients.  Cancer . 1987;  59 983-985
• 43 Geerts W H, Code K I, Jay R M, Chen E, Szalai J P. A prospective study of venous thromboembolism after major trauma.  N Engl J Med . 1994;  331(24) 1601-1606
• 44 Velmahos G C, Kern J, Chan L S, Oder D, Murray J A, Shekelle P. Prevention of venous thromboembolism after injury: an evidence-based report-Part I: Analysis of risk factors and evaluation of the role of vena cava filters.  J Trauma . 2000;  49(1) 132-139
• 45 Geerts W H, Jay R M, Code K I. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.  N Engl J Med . 1996;  335(10) 701-707
• 46 Linsenmaier U, Rieger J, Schenk F, Rock C, Mangel E, Pfeifer K J. Indications, management, and complications of temporary inferior vena cava filters.  Cardiovasc Intervent Radiol . 1998;  21 464-469